alexa Validation Of Epigenetic Therapeutic Target Proteins For Homogenous Assay Performance
ISSN: 2376-0419

Journal of Pharmaceutical Care & Health Systems
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

10TH Asia-Pacific Pharma Congress
May 08-10, 2017 Singapore

Masato Yonezawa
Active Motif Inc, USA
Posters & Accepted Abstracts: J Pharma Care Health Sys
DOI: 10.4172/2376-0419-C1-021
Abstract
Results from sequencing large numbers of normal vs. tumor samples from the cancer genome atlas project (TCGA) revealed a great number of potential new therapeutic targets among epigenetic enzymes and factors. An outcome of this large scale project is that there is significant interest in developing screening strategies for many of the classes of these proteins, including histone deacetylases (HDACs), histone acetyltransferases (HATs), lysine methyltransferases (KMTs), lysine demethylases (KDMs), and bromodomain containing proteins (bromodomains). While the activity of some of these targets have yet to be validated using screening platforms that use peptide substrates (i.e. Perkin Elmer AlphaLISA), Active Motif has produced a protein toolbox of reagents including active enzymes, recombinant substrates, and detection antibodies for homogenous assay platforms such as AlphaLISA. We have validated reagents used in these assays for targets HDAC3, LSD1, p300, SETDB1, and BRD family members to ensure our ability to validate these proteins for performance in screening assays. As assessed by AlphaLISA assays, the IC50 values for various reference compounds for the enzymes under evaluation, are well within published results. The protein toolbox continues to expand to include a range of enzyme substrates, from peptides and recombinant histones bearing post-translational modifications to more complex, and biologically contextual recombinant octamers, oligonucleosomes, and “designer” mononucleosomes, which include site directed post-translational modifications. The expanding portfolio of substrates will enable screens of additional therapeutic targets using these higher order nucleosome substrates which may enable identification of small molecule compounds which exhibit greater specificity or selectively in vivo relative to those currently identified using peptide substrates.
Biography

Masato Yonezawa has nearly a total of ~20 years of experience in epigenetics research in academia and industries. Analyzed epigenetic phenomena by means of molecular biology and biochemistry. He is highly skilled with enzymatic assays and screened several inhibitors of chromatin modifying enzymes and would like to contribute to epigenetic research and therapy by developing useful tools and drugs.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords